Aldolase B Deficient Mice Are Characterized by Hepatic Nucleotide Sugar Abnormalities
Journal of Inherited Metabolic Disease · 2025
DOI: 10.1002/jimd.12836 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2025. Verfasst von Amée M Buziau und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Endocrinology and Metabolic Disease, Maastricht University Medical Center+, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Liver, Fructose-Bisphosphate Aldolase, Mannose, Mice, Knockout. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Diabetes Fonds, Catalyst Grant from United for Metabolic Diseases, ZonMw.
Abstract (Originalsprache)
Hereditary fructose intolerance (HFI) is characterized by liver damage and a secondary defect in N‐linked glycosylation due to impairment of mannose phosphate isomerase (MPI). Mannose treatment has been shown to be an effective treatment in a primary defect in MPI (i.e., MPI‐CDG), which is also characterized by liver damage. Therefore, the aims of this study were to determine: (1) hepatic nucleotide sugar levels, and (2), the effect of mannose supplementation on hepatic nucleotide sugar levels and liver fat, in a mouse model for HFI. Aldolase B deficient mice ( Aldob −/− ) were treated for four weeks with 5% mannose via the drinking water and compared to Aldob −/ − mice and wildtype mice treated with regular drinking water. We found that hepatic GDP‐mannose and hepatic GDP‐fucose were lower in water‐treated Aldob −/ − mice when compared to water‐treated wildtype mice ( p = 0.002 and p = 0.002, respectively), consistent with impaired N‐linked glycosylation. Of interest, multiple other hepatic nucleotide sugars not involved in N‐linked glycosylation, such as hepatic UDP‐glucuronic acid, UDP‐xylose, CMP‐ N ‐acetyl‐beta‐neuraminic acid, and CDP‐ribitol ( p = 0.002, p = 0.003, p = 0.002, p = 0.002), were found to have altered levels as well. However, mannose treatment did not correct the reduction in hepatic GDP‐mannose levels, nor was liver fat affected. Aldob −/ − mice are characterized by hepatic nucleotide sugar abnormalities, but these were not abrogated by mannose treatment. Future studies are needed to identify the underlying mechanisms responsible for the abnormal hepatic nucleotide sugar pattern and intrahepatic lipid accumulation in HFI. Trial Registration: PCT ID: PCTE0000340, this animal experiment is registered at ( https://preclinicaltrials.eu/ ).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Endocrinology and Metabolic Disease, Maastricht University Medical Center+, Maastricht, The Netherlands.
- Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
- Department of Internal Medicine, Division of General Internal Medicine, Laboratory for Metabolism and Vascular Medicine, Maastricht University, Maastricht, The Netherlands.
- Translational Metabolic Laboratory, Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Gastroenterology-Hepatology and Metabolic Center, University Hospital Leuven, Leuven, Belgium.
ORCID-Profile: Martijn C G J Brouwers
Förderung
- Diabetes Fonds
- Catalyst Grant from United for Metabolic Diseases
- ZonMw
Zitieren
APA
Buziau, A. M., Lefeber, D. J., Cassiman, D., Rubio-Gozalbo, M. E., Kwast, H., Tolan, D. R., Schalkwijk, C. G., & Brouwers, M. C. G. J. (2025). Aldolase B Deficient Mice Are Characterized by Hepatic Nucleotide Sugar Abnormalities. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12836
Vancouver
Buziau AM, Lefeber DJ, Cassiman D, Rubio-Gozalbo ME, Kwast H, Tolan DR, et al. Aldolase B Deficient Mice Are Characterized by Hepatic Nucleotide Sugar Abnormalities. Journal of Inherited Metabolic Disease. 2025. doi:10.1002/jimd.12836
BibTeX
@article{Buziau2025,
author = {Buziau, Amée M and Lefeber, Dirk J and Cassiman, D and Rubio-Gozalbo, M Estela and Kwast, Hanneke and Tolan, Dean R and Schalkwijk, Casper G and Brouwers, Martijn C G J},
title = {Aldolase B Deficient Mice Are Characterized by Hepatic Nucleotide Sugar Abnormalities},
journal = {Journal of Inherited Metabolic Disease},
year = {2025},
doi = {10.1002/jimd.12836}
}
EUVIMED